WHO prequalifies Cipla’s ‘MEFLIAM Plus’ for treatment of malaria
MEFLIAM Plus, an Artesunate-Mefloquine fixed-dose combination to be rolled out throughout Asia
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.